Global Times: Marathons foster deeper integration of sports and culture
BEIJING,Dec. 2,2024-- Thousands of marathon runners gathered,stretched,and prepared at the starting line at theBund in Shanghai on Sunday morning,as the East China metropolis braced for one of its mos
SYDNEY,Dec. 2,2024-- Recently,Witsbb,a pioneer in "allergy-free" nutrition,has launched its latest product – the Elderberry Yeast β-glucan drink. As an immune-boosting nutritional product
MANILA,Philippines,Dec. 2,2024-- AdvantageClub.ai,a leader in employee engagement solutions,has raised $4 million in its latest funding round,bringing its total funding to $11 million. The round was l
HONG KONG,Dec. 2,2024-- Hong Kong Airlines celebrated its 18th anniversary on 28 November and announced the resumption of direct flights to Vancouver,Canada commencing 18 January 2025. The twice-weekl
Sustainable Energy Brand EBL to Unveil New Brand Identity and Innovative Power Solutions at CES 2025
SHENZHEN,China,Dec. 2,2024-- EBL,a pioneering sustainable energy brand committed to environmental protection,efficiency,and stability,is proud to announce that it will unveil its new brand image at CE
Hesai to Attend CES 2025, Launch Versatile New Mini 3D Lidar for Industrial and Robotic Applications
PALO ALTO,Calif.,Dec. 2,2024--Hesai (Nasdaq: HSAI),the global leader in lidar technology for robotics and industrial applications,autonomous driving,and ADAS,announced today that it will be exhibiting
Aon names Anne Corona as CEO of Enterprise Clients and Global Chief Commercial Officer
DUBLIN,Dec. 3,2024--Aon plc (NYSE: AON),a leading global professional services firm,today announces the appointment of Anne Corona as CEO of Enterprise Clients and global chief commercial officer,effe
Moon Creative Lab Venture Variloom™ Wins ISPO 2024 Award in Collaboration with Rip Curl
Variloom3DP Filament and Print System Recognized as Part of Rip Curl\'s Mirage3DP Boardshort Innovating in Sustainable and Functional Design and Materials
Fangzhou Inc. Announces Inclusion of Its Shares in Hang Seng Hong Kong-Listed Biotech Index
HONG KONG,Dec. 3,2024-- Fangzhou Inc.("Fangzhou" or the "Company") (06086.HK),a leader in Internet healthcare solutions,announced today that the Company\'s Ordinary Shares,which t
VVN461,a non-steroidal dual JAK1/TYK2 immunomodulator,achieves primary endpoint,demonstrating statistical and clinical efficacy compared to vehicle in treatingpost-operative inflammation following cat